Mesenchymal stem cell-based therapy for peripheral nerve injuries: A promise or reality?

doi:10.4252/wjsc.v17.i6.107833

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (190)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-4) series.

Item

Count

PDF

HTML

Figures (1-4)

Tables (1-4)

Sum=115

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=36

Publishing Process of This Article

Item

Count

Browse

Download

Sum=27

Jun 26, 2025 (publication date) through Jun 28, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Stem Cells. Jun 26, 2025; 17(6): 107833
Published online Jun 26, 2025. doi: 10.4252/wjsc.v17.i6.107833

Full Size Figure Download Figure

Figure 1 Schematic representation of the grading systems for peripheral nerve injuries. Neuropraxia (Sunderland: Grade I) involves focal demyelination. Axonotmesis is subdivided into grade II (axon and myelin damage), grade III (axon, myelin, and endoneurium damage), and grade IV (axon, myelin, endoneurium, and perineurium damage). Neurotmesis (grade V) is complete nerve transection. Created in BioRender. Amorim, R. (2025) https://BioRender.com/z6uzrjj.

Citation: Ferreira LVO, Roballo KCS, Amorim RM. Mesenchymal stem cell-based therapy for peripheral nerve injuries: A promise or reality? World J Stem Cells 2025; 17(6): 107833
URL: https://www.wjgnet.com/1948-0210/full/v17/i6/107833.htm
DOI: https://dx.doi.org/10.4252/wjsc.v17.i6.107833